There are currently 5 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street equities research...
crsp stock forecast
Earnings Trend: CRSP has become profitable over the past 5 years, growing earnings by 28.2% per year. Similarly, Is CRSP...
CRISPR Therapeutics ( CRSP 2.00% ), a company leaning on gene-editing technology to precisely alter genomic DNA and tackle hard-to-treat...
Largest shareholders include ARK Investment Management LLC, ARKK – ARK Innovation ETF, Nikko Asset Management Americas, Inc., Capital International Investors,...
